top of page

AREXVY Powder and Suspension for Suspension for Injection 120mcg/0.5mL

Product details

Registration number: SIN17008P

Classification: Prescription Only

Active ingredients: RSVPreF3 antigen

Strength: 120mcg/0.5mL

Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION

Route: INTRAMUSCULAR

Registrant: GLAXOSMITHKLINE PTE LTD

ATC code: J07BX05

HSA approval date: 10 May 2024

Manufacturer(s):

  • GlaxoSmithKline Biologicals SA
  • GlaxoSmithKline Biologicals SA (adjuvant)
  • GlaxoSmithKline Vaccines S.r.l. (adjuvant)
  • GlaxoSmithKline Biologicals SA (adjuvant)

Manufacturing country/countries: BELGIUM; ITALY

What are the HSA registration number and classification for AREXVY Powder and Suspension for Suspension for Injection 120mcg/0.5mL?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN17008P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for AREXVY Powder and Suspension for Suspension for Injection 120mcg/0.5mL?

According to the HSA dataset updated 7 August 2026:

Active ingredients: RSVPreF3 antigen

Strength: 120mcg/0.5mL

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for AREXVY Powder and Suspension for Suspension for Injection 120mcg/0.5mL?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION

Route: INTRAMUSCULAR

Source for this answer

Who is the recorded registrant for AREXVY Powder and Suspension for Suspension for Injection 120mcg/0.5mL?

According to the HSA dataset updated 7 August 2026:

Registrant: GLAXOSMITHKLINE PTE LTD

Source for this answer

Which manufacturers and countries are listed for AREXVY Powder and Suspension for Suspension for Injection 120mcg/0.5mL?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • GlaxoSmithKline Biologicals SA
  • GlaxoSmithKline Biologicals SA (adjuvant)
  • GlaxoSmithKline Vaccines S.r.l. (adjuvant)
  • GlaxoSmithKline Biologicals SA (adjuvant)

Manufacturing country/countries: BELGIUM; ITALY

Source for this answer

Where can I look up AREXVY Powder and Suspension for Suspension for Injection 120mcg/0.5mL in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN17008P or the exact product name AREXVY Powder and Suspension for Suspension for Injection 120mcg/0.5mL. The general register link does not preselect this product.

Source for this answer

What are the source dates for this AREXVY Powder and Suspension for Suspension for Injection 120mcg/0.5mL record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this AREXVY Powder and Suspension for Suspension for Injection 120mcg/0.5mL record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN17008P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page